Isomorphic Labs
AI drug discovery company using frontier models to design medicines
Updated May 2026
Overview
- Website
- isomorphiclabs.com
- Segment
- AI for Healthcare
Moat
- Proprietary Technology
- Proprietary Data
- Talent
- Scale Advantages
- Data Flywheel
Isomorphic Labs’ moat appears to come from proprietary AI drug-design technology built on DeepMind/AlphaFold expertise, plus proprietary data and model improvements from its ongoing drug discovery programs. Its access to top-tier talent and capital, combined with integration across models, chemistry, and biology, can create compounding advantages over time.